Whole transcriptome profiling of PBMCs further showed overexpression of complete NOD-like receptor pathway and components of downstream NFKB, JNK and p38 pathways which were previously implicated in the MS pathology13–15. This evidence concerns the gene NFKB1 and myeloid sarcoma.